GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for tyrosine 2,3-aminomutase (B8ZV93)

Analyse AlphaFold monomer V2.0 prediction for tyrosine 2,3-aminomutase (B8ZV93) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B8ZV93
Type
protein
Length
526 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x6Ed09D80e98fE15DE51C9E7a8896AbF1f2365C3e
Molecule
Tyrosine 2,3-aminomutase
UniProt
B8ZV93
Pockets
4 · best druggability 0.50

Structure

1 distinct chain · 58% helix, 6% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine 2,3-aminomutaseprotein52658% helix, 6% strandB8ZV93

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11310.500.8020empty
2930.480.8115empty
3880.380.7614empty
4610.290.7414empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.